Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence.
Here we report the structural characterization of the product formed from the reaction between hydroethidine (HE) and superoxide (O(2)(.-)). By using mass spectral and NMR techniques, the chemical structure of this product was determined as 2-hydroxyethidium (2-OH-E(+)). By using an authentic standard, we developed an HPLC approach to detect and quantitate the reaction product of HE and O(2)(.-) formed in bovine aortic endothelial cells after treatment with menadione or antimycin A to induce intracellular reactive oxygen species. Concomitantly, we used a spin trap, 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BMPO), to detect and identify the structure of reactive oxygen species formed. BMPO trapped the O(2)(.-) that formed extracellularly and was detected as the BMPO-OH adduct during use of the EPR technique. BMPO, being cell-permeable, inhibited the intracellular formation of 2-OH-E(+). However, the intracellular BMPO spin adduct was not detected. The definitive characterization of the reaction product of O(2)(.-) with HE described here forms the basis of an unambiguous assay for intracellular detection and quantitation of O(2)(.-). Analysis of the fluorescence characteristics of ethidium (E(+)) and 2-OH-E(+) strongly suggests that the currently available fluorescence methodology is not suitable for quantitating intracellular O(2)(.-). We conclude that the HPLC/fluorescence assay using HE as a probe is more suitable [corrected] for detecting intracellular O(2)(.-).
Zhao
Hongtao
H
Department of Biophysics and Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Joseph
Joy
J
Fales
Henry M
HM
Sokoloski
Edward A
EA
Levine
Rodney L
RL
Vasquez-Vivar
Jeannette
J
Kalyanaraman
B
B
D000818:Animals; D001011:Aorta / Q000166:cytology; D001681:Biological Assay / Q000379:methods*; D002417:Cattle; D002518:Ceramides / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003497:Cyclic N-Oxides / Q000737:chemistry; D042783:Endothelial Cells / Q000737:chemistry / Q000187:drug effects; D005456:Fluorescent Dyes / Q000737:chemistry*; D015394:Molecular Structure; D010084:Oxidation-Reduction; D010617:Phenanthridines / Q000737:chemistry*; D017382:Reactive Oxygen Species / Q000737:chemistry; D019097:Spin Trapping; D013481:Superoxides / Q000737:chemistry*; D024483:Vitamin K 3 / Q000737:chemistry
C441196:5-tert-butoxycarbonyl 5-methyl-1-pyrroline N-oxide; D002518:Ceramides; D003497:Cyclic N-Oxides; D005456:Fluorescent Dyes; D010617:Phenanthridines; D017382:Reactive Oxygen Species; D013481:Superoxides; C058428:hydroethidine; D024483:Vitamin K 3